Expression and Correlation of Vascular Endothelial Growth Factor and Estrogen Receptor in Endometrial Carcinomas
WANG Wen-dong,ZHANG You-zhong,BAI Xiao-xia
DOI: https://doi.org/10.3969/j.issn.1673-5269.2005.05.015
2005-01-01
Abstract:OBJECTIVE:To explore the expression and correlation of vascular endothelial growth factor (VEGF) and estrogen receptor (ER) in endometrial carcinomas. METHODS: Expression of VEGF and ER in 30 samples of normal endometrium, 30 samples of endometrial hyperplasia and 50 samples of endometrial carcinomas were analyses by using immunohistochemistry. RESULTS: Expression of VEGF in endometrial carcinomas (64.0%,32/50) was significantly higher than that in normal endometrium (0,0/30), P=0.002 5 and endometrial hyperplasia (0,0/30), P=0.002 5, and the result of ER (82.%,41/50) was inverse,P=0.031. Expression of ER in nonendometrioid carcinomas (50.%,6/12) was lower than that in endometrioid carcinoma (92.1%,35/38), P=0.044. Expression of ER in Grade 3 endometrial carcinomas (50.0%, 5/10) was remarkably lower than that in Grade 1 (95.2%, 20/21), P=0.045 and Group 2 (84.2%,16/19), P=0.039. Expression of ER in Stage Ⅲ endometrial carcinomas (42.9%, 3/7) was lower than that in Stage Ⅰ (93.8%,30/32), P=0.029 and Stage Ⅱ (72.7%,8/11), P=0.049. Expression of VEGF in Grade 3 endometrial carcinomas (100.0%,10/10) was significantly higher than that in Grade 1 (76.2,16/21), P=0.048 and Grade 2 (84.2%,16/19), P=0.049. No correlation was found between expression of VEGF in endometrial carcinomas and FIGO stage and histologic type, P=0.26. The expression of VEGF had inverse correlation with the expression of ER in endometrial carcinomas,r=-0.421 6,t r=-3.970 5,P=0.005 1.CONCLUSIONS: Expression of ER in endometrial carcinomas has correlation with the tumorigenicity and prognosis of endometrial carcinomas and that of VEGF has correlation with the tumorigenicity and rapid tumor growth. ER may influence the biologic characteristics of endometrial carcinoma through certain interaction with VEGF.